{
    "organizations": [],
    "uuid": "59147f26c860c8372d7943b46062af78d7d84f31",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-betta-pharmaceuticals-sees-fy-2018/brief-betta-pharmaceuticals-sees-fy-2018-q1-net-profit-down-40-pct-to-45-pct-idUSL3N1RN46U",
    "ord_in_thread": 0,
    "title": "BRIEF-Betta Pharmaceuticals sees FY 2018 Q1 net profit down 40 pct to 45 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - Betta Pharmaceuticals Co Ltd\n* Says it sees net profit for FY 2018 Q1 to decrease by 40 percent to 45 percent, or to be 41.6 million yuan to 45.3 million yuan\n* Says the net profit of FY 2017 Q1 was 75.5 million yuan\n* Comments that increased research and development costs as main reason for the forecast\nSource text in Chinese: goo.gl/jp5T7g\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-10T18:42:00.000+03:00",
    "crawled": "2018-04-11T18:26:28.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "betta",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "see",
        "net",
        "profit",
        "fy",
        "q1",
        "decrease",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "net",
        "profit",
        "fy",
        "q1",
        "million",
        "yuan",
        "comment",
        "increased",
        "research",
        "development",
        "cost",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}